Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Kidney Transplantation

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 153 articles:
HTML format



Single Articles


    January 2020
  1. TEIXEIRA CM, Tedesco Silva Junior H, Moura LAR, Proenca HMS, et al
    Clinical and pathological features of thrombotic microangiopathy influencing long-term kidney transplant outcomes.
    PLoS One. 2020;15:e0227445.
    PubMed     Abstract available


  2. LECRONIER M, Tashk P, Tamzali Y, Tenaillon O, et al
    Gut microbiota composition alterations are associated with the onset of diabetes in kidney transplant recipients.
    PLoS One. 2020;15:e0227373.
    PubMed     Abstract available



  3. Correction: A qualitative examination of barriers and solutions to renal transplantation in Malaysia: Key-informants' perspective.
    PLoS One. 2020;15:e0228662.
    PubMed     Abstract available


  4. DA COSTA LA, Andreoli MCC, Carvalho AB, Draibe SA, et al
    Clinical outcomes of incident peritoneal dialysis patients coming from kidney transplantation program: A case-control study.
    PLoS One. 2020;15:e0227870.
    PubMed     Abstract available


  5. BETJES MGH, Litjens NHR
    High numbers of differentiated CD28null CD8+ T cells are associated with a lowered risk for late rejection and graft loss after kidney transplantation.
    PLoS One. 2020;15:e0228096.
    PubMed     Abstract available


  6. DOS SANTOS MANTOVANI M, Coelho de Carvalho N, Archangelo TE, Modelli de Andrade LG, et al
    Frailty predicts surgical complications after kidney transplantation. A propensity score matched study.
    PLoS One. 2020;15:e0229531.
    PubMed     Abstract available


  7. PFLUGRAD H, Nosel P, Ding X, Schmitz B, et al
    Brain function and metabolism in patients with long-term tacrolimus therapy after kidney transplantation in comparison to patients after liver transplantation.
    PLoS One. 2020;15:e0229759.
    PubMed     Abstract available


  8. MIYATAKE N, Adachi H, Nomura-Nakayama K, Okada K, et al
    Circulating CTRP9 correlates with the prevention of aortic calcification in renal allograft recipients.
    PLoS One. 2020;15:e0226526.
    PubMed     Abstract available


  9. MUNSHI VN, Saghafian S, Cook CB, Werner KT, et al
    Comparison of post-transplantation diabetes mellitus incidence and risk factors between kidney and liver transplantation patients.
    PLoS One. 2020;15:e0226873.
    PubMed     Abstract available


  10. KOVACS G, Devercelli G, Zelei T, Hirji I, et al
    Association between transplant glomerulopathy and graft outcomes following kidney transplantation: A meta-analysis.
    PLoS One. 2020;15:e0231646.
    PubMed     Abstract available


  11. SELISTRE LDS, Lemoine S, Dantec A, Buron F, et al
    Comparison of creatinine-based equations for estimating glomerular filtration rate in deceased donor renal transplant recipients.
    PLoS One. 2020;15:e0231873.
    PubMed     Abstract available


  12. COSTA SD, de Andrade LGM, Barroso FVC, Oliveira CMC, et al
    The impact of deceased donor maintenance on delayed kidney allograft function: A machine learning analysis.
    PLoS One. 2020;15:e0228597.
    PubMed     Abstract available


  13. KO EJ, Seo JW, Kim KW, Kim BM, et al
    Phenotype and molecular signature of CD8+ T cell subsets in T cell- mediated rejections after kidney transplantation.
    PLoS One. 2020;15:e0234323.
    PubMed     Abstract available


  14. JUN H, Kim YH, Kim JK, Kim CD, et al
    Outcomes of kidney transplantation from elderly deceased donors of a Korean registry.
    PLoS One. 2020;15:e0232177.
    PubMed     Abstract available


  15. POOL MBF, Hartveld L, Leuvenink HGD, Moers C, et al
    Normothermic machine perfusion of ischaemically damaged porcine kidneys with autologous, allogeneic porcine and human red blood cells.
    PLoS One. 2020;15:e0229566.
    PubMed     Abstract available


  16. BARDOWSKA K, Letachowicz K, Kaminska D, Kusztal M, et al
    The attitude of kidney transplant recipients towards elective arteriovenous fistula ligation.
    PLoS One. 2020;15:e0234931.
    PubMed     Abstract available


  17. JUNG HY, Seo MY, Jeon Y, Huh KH, et al
    Tacrolimus trough levels higher than 6 ng/mL might not be required after a year in stable kidney transplant recipients.
    PLoS One. 2020;15:e0235418.
    PubMed     Abstract available


  18. ELSHAHAT S, Cockwell P, Maxwell AP, Griffin M, et al
    The impact of chronic kidney disease on developed countries from a health economics perspective: A systematic scoping review.
    PLoS One. 2020;15:e0230512.
    PubMed     Abstract available


    January 2019
  19. MARK E, Goldsman D, Gurbaxani B, Keskinocak P, et al
    Using machine learning and an ensemble of methods to predict kidney transplant survival.
    PLoS One. 2019;14:e0209068.
    PubMed     Abstract available


  20. DAVIDSON B, Du Toit T, Jones ESW, Barday Z, et al
    Outcomes and challenges of a kidney transplant programme at Groote Schuur Hospital, Cape Town: A South African perspective.
    PLoS One. 2019;14:e0211189.
    PubMed     Abstract available


  21. BATH NM, Ding X, Wilson NA, Verhoven BM, et al
    Desensitization and treatment with APRIL/BLyS blockade in rodent kidney transplant model.
    PLoS One. 2019;14:e0211865.
    PubMed     Abstract available


  22. DUNN T, Saeed MJ, Shpigel A, Novak E, et al
    The association of preoperative cardiac stress testing with 30-day death and myocardial infarction among patients undergoing kidney transplantation.
    PLoS One. 2019;14:e0211161.
    PubMed     Abstract available



  23. Correction: Alteration of urinary neutrophil gelatinase-associated lipocalin as a predictor of tacrolimus-induced chronic renal allograft fibrosis in tacrolimus dose adjustments following kidney transplantation.
    PLoS One. 2019;14:e0213009.
    PubMed     Abstract available


  24. FELTEN R, Perrin P, Caillard S, Moulin B, et al
    Avascular osteonecrosis in kidney transplant recipients: Risk factors in a recent cohort study and evaluation of the role of secondary hyperparathyroidism.
    PLoS One. 2019;14:e0212931.
    PubMed     Abstract available


  25. RODELO-HAAD C, Aguera ML, Carmona A, Navarro MD, et al
    Pancreatic autoantibodies and CD14+CD16+ monocytes subset are associated with the impairment of ss-cell function after simultaneous pancreas-kidney transplantation.
    PLoS One. 2019;14:e0212547.
    PubMed     Abstract available


  26. NIELSEN MB, Krogstrup NV, Nieuwenhuijs-Moeke GJ, Oltean M, et al
    P-NGAL Day 1 predicts early but not one year graft function following deceased donor kidney transplantation - The CONTEXT study.
    PLoS One. 2019;14:e0212676.
    PubMed     Abstract available


  27. SCHUTTE-NUTGEN K, Finke M, Ehlert S, Tholking G, et al
    Expanding the donor pool in kidney transplantation: Should organs with acute kidney injury be accepted?-A retrospective study.
    PLoS One. 2019;14:e0213608.
    PubMed     Abstract available


  28. GARNIER AS, Planchais M, Riou J, Jacquemin C, et al
    Pre-transplant CD45RC expression on blood T cells differentiates patients with cancer and rejection after kidney transplantation.
    PLoS One. 2019;14:e0214321.
    PubMed     Abstract available


  29. TILLMANN FP, Quack I, Woznowski M, Rump LC, et al
    Effect of recipient-donor sex and weight mismatch on graft survival after deceased donor renal transplantation.
    PLoS One. 2019;14:e0214048.
    PubMed     Abstract available


  30. LEE S, Yoo KD, An JN, Oh YK, et al
    Factors affecting mortality during the waiting time for kidney transplantation: A nationwide population-based cohort study using the Korean Network for Organ Sharing (KONOS) database.
    PLoS One. 2019;14:e0212748.
    PubMed     Abstract available


  31. RHU J, Kim SJ, Lee KW, Park JB, et al
    Development of a novel linear model for predicting recipient's post-transplant serum creatinine level after living donor kidney transplantation: A multicenter cross-validation study.
    PLoS One. 2019;14:e0214247.
    PubMed     Abstract available


  32. TRAITANON O, Mathew JM, Shetty A, Bontha SV, et al
    Mechanistic analyses in kidney transplant recipients prospectively randomized to two steroid free regimen-Low dose Tacrolimus with Everolimus versus standard dose Tacrolimus with Mycophenolate Mofetil.
    PLoS One. 2019;14:e0216300.
    PubMed     Abstract available


  33. RIEGERSPERGER M, Plischke M, Jallitsch-Halper A, Steinhauser C, et al
    A non-randomized trial of conversion from ciclosporin and tacrolimus to tacrolimus MR4 in stable long-term kidney transplant recipients: Graft function and influences of ABCB1 genotypes.
    PLoS One. 2019;14:e0218709.
    PubMed     Abstract available


  34. SIGDEL TK, Yang JYC, Bestard O, Schroeder A, et al
    A urinary Common Rejection Module (uCRM) score for non-invasive kidney transplant monitoring.
    PLoS One. 2019;14:e0220052.
    PubMed     Abstract available


  35. GAN KIM SOON P, Lim SK, Rampal S, Su TT, et al
    A qualitative examination of barriers and solutions to renal transplantation in Malaysia: Key-informants' perspective.
    PLoS One. 2019;14:e0220411.
    PubMed     Abstract available


  36. SHAH S, Christianson AL, Verma P, Meganathan K, et al
    Racial disparities and factors associated with pregnancy in kidney transplant recipients in the United States.
    PLoS One. 2019;14:e0220916.
    PubMed     Abstract available


  37. COUSSEMENT J, Scemla A, Hougardy JM, Sberro-Soussan R, et al
    Prevalence of asymptomatic bacteriuria among kidney transplant recipients beyond two months post-transplant: A multicenter, prospective, cross-sectional study.
    PLoS One. 2019;14:e0221820.
    PubMed     Abstract available


  38. CHUANG YW, Huang ST, Yu TM, Li CY, et al
    Acute pancreatitis risk after kidney transplantation: Propensity score matching analysis of a national cohort.
    PLoS One. 2019;14:e0222169.
    PubMed     Abstract available


  39. BRAKEMEIER S, Arns W, Lehner F, Witzke O, et al
    Everolimus in de novo kidney transplant recipients participating in the Eurotransplant senior program: Results of a prospective randomized multicenter study (SENATOR).
    PLoS One. 2019;14:e0222730.
    PubMed     Abstract available


  40. LIM JH, Cho JH, Jung HY, Choi JY, et al
    Excellent outcome after desensitization in high immunologic risk kidney transplantation.
    PLoS One. 2019;14:e0222537.
    PubMed     Abstract available


  41. MOTA-ZAMORANO S, Gonzalez LM, Luna E, Fernandez JJ, et al
    Polymorphisms in vasoactive eicosanoid genes of kidney donors affect biopsy scores and clinical outcomes in renal transplantation.
    PLoS One. 2019;14:e0224129.
    PubMed     Abstract available


  42. GIRE DAHL K, Engebretsen E, Andersen MH, Urstad KH, et al
    The trigger-information-response model: Exploring health literacy during the first six months following a kidney transplantation.
    PLoS One. 2019;14:e0223533.
    PubMed     Abstract available


  43. BUTLER CR, Perkins JD, Johnson CK, Blosser CD, et al
    Burden of excess mortality after implementation of the new kidney allocation system may be borne disproportionately by middle-aged recipients.
    PLoS One. 2019;14:e0210589.
    PubMed     Abstract available


  44. BATH NM, Ding X, Verhoven BM, Wilson NA, et al
    Autoantibody production significantly decreased with APRIL/BLyS blockade in murine chronic rejection kidney transplant model.
    PLoS One. 2019;14:e0223889.
    PubMed     Abstract available


  45. TOMITA Y, Iwadoh K, Ogawa Y, Miki K, et al
    Single fixed low-dose rituximab as induction therapy suppresses de novo donor-specific anti-HLA antibody production in ABO compatible living kidney transplant recipients.
    PLoS One. 2019;14:e0224203.
    PubMed     Abstract available


  46. NAKID-CORDERO C, Arzouk N, Gauthier N, Tarantino N, et al
    Skewed T cell responses to Epstein-Barr virus in long-term asymptomatic kidney transplant recipients.
    PLoS One. 2019;14:e0224211.
    PubMed     Abstract available


  47. LUMLEY S, Green C, Rafferty H, Smith C, et al
    Cytomegalovirus viral load parameters associated with earlier initiation of pre-emptive therapy after solid organ transplantation.
    PLoS One. 2019;14:e0210420.
    PubMed     Abstract available


  48. FERNANDES-CHARPIOT IMM, Estofolete CF, Caldas HC, de Souza GR, et al
    Clinical and laboratorial profiles of dengue virus infection in kidney transplant recipients: Report of a single center.
    PLoS One. 2019;14:e0219117.
    PubMed     Abstract available


  49. HAN A, Min SI, Ahn S, Min SK, et al
    Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: A randomized controlled trial.
    PLoS One. 2019;14:e0224595.
    PubMed     Abstract available


  50. VASCONCELOS ORDONES F, Pajolli PIR, Guerra da Silva R, Yamamoto HA, et al
    Impact of adjusted kidney volume measured in the bench surgery on one-year renal function in kidney transplantation.
    PLoS One. 2019;14:e0224364.
    PubMed     Abstract available


  51. HAUER V, Risti M, Miranda BLM, da Silva JS, et al
    The association of HLA-G polymorphisms and the synergistic effect of sMICA and sHLA-G with chronic kidney disease and allograft acceptance.
    PLoS One. 2019;14:e0212750.
    PubMed     Abstract available


  52. JEONG S, Kwon H, Kim JY, Kim YH, et al
    Effect of arteriovenous access closure and timing on kidney function in kidney transplant recipients.
    PLoS One. 2019;14:e0226309.
    PubMed     Abstract available


  53. NAKAZAWA R, Yoshiike M, Nozawa S, Aida K, et al
    Clinically useful limited sampling strategy to estimate area under the concentration-time curve of once-daily tacrolimus in adult Japanese kidney transplant recipients.
    PLoS One. 2019;14:e0225878.
    PubMed     Abstract available


  54. SNIJDERS MLH, Hesselink DA, Clahsen-van Groningen MC, Roodnat JI, et al
    Oxalate deposition in renal allograft biopsies within 3 months after transplantation is associated with allograft dysfunction.
    PLoS One. 2019;14:e0214940.
    PubMed     Abstract available


  55. MIYAZAKI R, Hoka S, Yamaura K
    Visceral fat, but not subcutaneous fat, is associated with lower core temperature during laparoscopic surgery.
    PLoS One. 2019;14:e0218281.
    PubMed     Abstract available


  56. BEAUDREUIL S, Zhang X, Herr F, Harper F, et al
    Circulating CASK is associated with recurrent focal segmental glomerulosclerosis after transplantation.
    PLoS One. 2019;14:e0219353.
    PubMed     Abstract available


  57. YANG WL, Bose B, Zhang L, Mcstea M, et al
    Long-term outcomes of patients with end-stage kidney disease due to membranous nephropathy: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry.
    PLoS One. 2019;14:e0221531.
    PubMed     Abstract available


  58. LEAL-COSTA C, Ramos-Morcillo AJ, Martinez Zaragoza F, Bernabeu Juan P, et al
    Personality and psychopathology in potential live kidney donors: A cluster analysis of personality features.
    PLoS One. 2019;14:e0221222.
    PubMed     Abstract available


  59. SORTICA DA, Crispim D, Bauer AC, Nique PS, et al
    K121Q polymorphism in the Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 gene is associated with acute kidney rejection.
    PLoS One. 2019;14:e0219062.
    PubMed     Abstract available


  60. KOBAYASHI E, Sano M
    Organ preservation solution containing dissolved hydrogen gas from a hydrogen-absorbing alloy canister improves function of transplanted ischemic kidneys in miniature pigs.
    PLoS One. 2019;14:e0222863.
    PubMed     Abstract available


  61. DELECLUSE S, Yu J, Bernhardt K, Haar J, et al
    Spontaneous lymphoblastoid cell lines from patients with Epstein-Barr virus infection show highly variable proliferation characteristics that correlate with the expression levels of viral microRNAs.
    PLoS One. 2019;14:e0222847.
    PubMed     Abstract available


  62. XIAO L, Jia L, Li R, Zhang Y, et al
    Early versus late initiation of renal replacement therapy for acute kidney injury in critically ill patients: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0223493.
    PubMed     Abstract available


  63. HUGHES JT, Freeman N, Beaton B, Puruntatemeri AM, et al
    My experiences with kidney care: A qualitative study of adults in the Northern Territory of Australia living with chronic kidney disease, dialysis and transplantation.
    PLoS One. 2019;14:e0225722.
    PubMed     Abstract available


    January 2018
  64. MAIER HT, Ashraf MI, Denecke C, Weiss S, et al
    Prediction of delayed graft function and long-term graft survival by serum and urinary neutrophil gelatinase-associated lipocalin during the early postoperative phase after kidney transplantation.
    PLoS One. 2018;13:e0189932.
    PubMed     Abstract available


  65. SEEGER H, Lindenmeyer MT, Cohen CD, Jaeckel C, et al
    Lymphotoxin expression in human and murine renal allografts.
    PLoS One. 2018;13:e0189396.
    PubMed     Abstract available


  66. YAZBEK DC, Carvalho AB, Barros CS, Medina Pestana JO, et al
    Is there relationship between epicardial fat and cardiovascular parameters in incident kidney transplant patients? A post-hoc analysis.
    PLoS One. 2018;13:e0191009.
    PubMed     Abstract available


  67. SCHREIBER PW, Bischoff-Ferrari HA, Boggian K, Bonani M, et al
    Bone metabolism dynamics in the early post-transplant period following kidney and liver transplantation.
    PLoS One. 2018;13:e0191167.
    PubMed     Abstract available


  68. WERZOWA JM, Saemann MD, Mohl A, Bergmann M, et al
    A randomized controlled trial-based algorithm for insulin-pump therapy in hyperglycemic patients early after kidney transplantation.
    PLoS One. 2018;13:e0193569.
    PubMed     Abstract available


  69. HERNANDEZ D, Muriel A, Castro de la Nuez P, Alonso-Titos J, et al
    Survival in Southern European patients waitlisted for kidney transplant after graft failure: A competing risk analysis.
    PLoS One. 2018;13:e0193091.
    PubMed     Abstract available


  70. NICOLETTO BB, Pedrollo EF, Carpes LS, Coloretti NG, et al
    Progranulin serum levels in human kidney transplant recipients: A longitudinal study.
    PLoS One. 2018;13:e0192959.
    PubMed     Abstract available


  71. CHANOUZAS D, Small A, Borrows R, Ball S, et al
    Assessment of the T-SPOT.CMV interferon-gamma release assay in renal transplant recipients: A single center cohort study.
    PLoS One. 2018;13:e0193968.
    PubMed     Abstract available


  72. THISHYA K, Vattam KK, Naushad SM, Raju SB, et al
    Artificial neural network model for predicting the bioavailability of tacrolimus in patients with renal transplantation.
    PLoS One. 2018;13:e0191921.
    PubMed     Abstract available


  73. PISAVADIA B, Arshad A, Chappelow I, Nightingale P, et al
    Ethnicity matching and outcomes after kidney transplantation in the United Kingdom.
    PLoS One. 2018;13:e0195038.
    PubMed     Abstract available


  74. IGLESIAS-ESCUDERO M, Moro-Garcia MA, Marcos-Fernandez R, Garcia-Torre A, et al
    Levels of anti-CMV antibodies are modulated by the frequency and intensity of virus reactivations in kidney transplant patients.
    PLoS One. 2018;13:e0194789.
    PubMed     Abstract available


  75. HAN A, Ahn S, Min SK, Ha J, et al
    Value of perioperative genitourinary screening culture and colonization status in predicting early urinary tract infection after renal transplantation.
    PLoS One. 2018;13:e0196115.
    PubMed     Abstract available


  76. KIM YC, Shin N, Lee S, Hyuk H, et al
    Effect of post-transplant glycemic control on long-term clinical outcomes in kidney transplant recipients with diabetic nephropathy: A multicenter cohort study in Korea.
    PLoS One. 2018;13:e0195566.
    PubMed     Abstract available


  77. WU W, Yang M, Xu M, Ding C, et al
    Diagnostic delay and mortality of active tuberculosis in patients after kidney transplantation in a tertiary care hospital in China.
    PLoS One. 2018;13:e0195695.
    PubMed     Abstract available


  78. WOLF S, Hoffmann VS, Habicht A, Kauke T, et al
    Effects of mTOR-Is on malignancy and survival following renal transplantation: A systematic review and meta-analysis of randomized trials with a minimum follow-up of 24 months.
    PLoS One. 2018;13:e0194975.
    PubMed     Abstract available


  79. GARNIER AS, Duveau A, Demiselle J, Croue A, et al
    Early post-transplant serum IgA level is associated with IgA nephropathy recurrence after kidney transplantation.
    PLoS One. 2018;13:e0196101.
    PubMed     Abstract available


  80. CHEDDANI L, Radulescu C, Chaignon M, Karras A, et al
    From arterial stiffness to kidney graft microvasculature: Mortality and graft survival within a cohort of 220 kidney transplant recipients.
    PLoS One. 2018;13:e0195928.
    PubMed     Abstract available


  81. KRAAL LJN, Nijland ML, Germar KL, Baeten DLP, et al
    Anti-citrullinated protein antibody response after primary EBV infection in kidney transplant patients.
    PLoS One. 2018;13:e0197219.
    PubMed     Abstract available


  82. HERNANDEZ MJ, Dos Reis LM, Marques ID, Araujo MJ, et al
    The effect of vitamin D and zoledronic acid in bone marrow adiposity in kidney transplant patients: A post hoc analysis.
    PLoS One. 2018;13:e0197994.
    PubMed     Abstract available


  83. SCHLOTT F, Steubl D, Ameres S, Moosmann A, et al
    Characterization and clinical enrichment of HLA-C*07:02-restricted Cytomegalovirus-specific CD8+ T cells.
    PLoS One. 2018;13:e0193554.
    PubMed     Abstract available


  84. BENJAMENS S, Pol RA, de Geus-Oei LF, de Vries APJ, et al
    Can transplant renal scintigraphy predict the duration of delayed graft function? A dual center retrospective study.
    PLoS One. 2018;13:e0193791.
    PubMed     Abstract available


  85. YAMANAGA S, Rosario A, Fernandez D, Kobayashi T, et al
    Inferior long-term graft survival after end-to-side reconstruction for two renal arteries in living donor renal transplantation.
    PLoS One. 2018;13:e0199629.
    PubMed     Abstract available


  86. KIM KW, Kim BM, Doh KC, Kim CD, et al
    Clinical significance of CD161+CD4+ T cells in the development of chronic antibody-mediated rejection in kidney transplant recipients.
    PLoS One. 2018;13:e0200631.
    PubMed     Abstract available


  87. NIEUWENHUIJS-MOEKE GJ, van den Berg TAJ, Bakker SJL, van den Heuvel MC, et al
    Preemptively and non-preemptively transplanted patients show a comparable hypercoagulable state prior to kidney transplantation compared to living kidney donors.
    PLoS One. 2018;13:e0200537.
    PubMed     Abstract available


  88. WALDER A, Muller M, Dahdal S, Sidler D, et al
    The effect of a previous created distal arteriovenous-fistula on radial bone DXA measurements in prevalent renal transplant recipients.
    PLoS One. 2018;13:e0200708.
    PubMed     Abstract available


  89. KANNEGIETER NM, Hesselink DA, Dieterich M, de Graav GN, et al
    Analysis of NFATc1 amplification in T cells for pharmacodynamic monitoring of tacrolimus in kidney transplant recipients.
    PLoS One. 2018;13:e0201113.
    PubMed     Abstract available


  90. CALVINO J, Cigarran S, Gonzalez-Tabares L, Menendez N, et al
    Advanced glycation end products (AGEs) estimated by skin autofluorescence are related with cardiovascular risk in renal transplant.
    PLoS One. 2018;13:e0201118.
    PubMed     Abstract available


  91. GANDOLFINI I, Crespo E, Baweja M, Jarque M, et al
    Impact of preformed T-cell alloreactivity by means of donor-specific and panel of reactive T cells (PRT) ELISPOT in kidney transplantation.
    PLoS One. 2018;13:e0200696.
    PubMed     Abstract available


  92. NOMURA-NAKAYAMA K, Adachi H, Miyatake N, Hayashi N, et al
    High molecular weight adiponectin inhibits vascular calcification in renal allograft recipients.
    PLoS One. 2018;13:e0195066.
    PubMed     Abstract available


  93. HAMOUDA E, El-Metwally S, Tarek M
    Ant Lion Optimization algorithm for kidney exchanges.
    PLoS One. 2018;13:e0196707.
    PubMed     Abstract available


  94. KERVINEN MH, Lehto S, Helve J, Gronhagen-Riska C, et al
    Type 2 diabetic patients on renal replacement therapy: Probability to receive renal transplantation and survival after transplantation.
    PLoS One. 2018;13:e0201478.
    PubMed     Abstract available


  95. MATZ M, Heinrich F, Lorkowski C, Wu K, et al
    MicroRNA regulation in blood cells of renal transplanted patients with interstitial fibrosis/tubular atrophy and antibody-mediated rejection.
    PLoS One. 2018;13:e0201925.
    PubMed     Abstract available


  96. SABLIK KA, Clahsen-van Groningen MC, Hesselink DA, van Gelder T, et al
    Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection.
    PLoS One. 2018;13:e0196552.
    PubMed     Abstract available


  97. JANSZ TT, Neradova A, van Ballegooijen AJ, Verhaar MC, et al
    The role of kidney transplantation and phosphate binder use in vitamin K status.
    PLoS One. 2018;13:e0203157.
    PubMed     Abstract available


  98. HABETS THPM, Hepkema BG, Kouprie N, Schnijderberg MCA, et al
    The prevalence of antibodies against the HLA-DRB3 protein in kidney transplantation and the correlation with HLA expression.
    PLoS One. 2018;13:e0203381.
    PubMed     Abstract available


  99. ZHOU CC, Ge YZ, Yao WT, Wu R, et al
    Correction: Limited Clinical Utility of Remote Ischemic Conditioning in Renal Transplantation: A Meta-Analysis of Randomized Controlled Trials.
    PLoS One. 2018;13:e0204184.
    PubMed     Abstract available


  100. LOPEZ-LOPEZ I, Rodelo-Haad C, Aguera ML, Cabello-Jabalquinto R, et al
    Administration of mycophenolic acid is not associated with malformations in descendants from kidney transplanted males.
    PLoS One. 2018;13:e0202589.
    PubMed     Abstract available


  101. JANSZ TT, Bonenkamp AA, Boereboom FTJ, van Reekum FE, et al
    Health-related quality of life compared between kidney transplantation and nocturnal hemodialysis.
    PLoS One. 2018;13:e0204405.
    PubMed     Abstract available


  102. LIM JH, Lee CH, Kim KY, Jung HY, et al
    Novel urinary exosomal biomarkers of acute T cell-mediated rejection in kidney transplant recipients: A cross-sectional study.
    PLoS One. 2018;13:e0204204.
    PubMed     Abstract available


  103. PATERSON TSE, O'Rourke N, Shapiro RJ, Loken Thornton W, et al
    Medication adherence in renal transplant recipients: A latent variable model of psychosocial and neurocognitive predictors.
    PLoS One. 2018;13:e0204219.
    PubMed     Abstract available


  104. LEE H, Han E, Choi AR, Ban TH, et al
    Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients.
    PLoS One. 2018;13:e0207434.
    PubMed     Abstract available


  105. KEDDIS MT, Sharma A, Ilyas M, Zhang N, et al
    Transplant center assessment of the inequity in the kidney transplant process and outcomes for the Indigenous American patients.
    PLoS One. 2018;13:e0207819.
    PubMed     Abstract available


  106. GIELIS EM, Beirnaert C, Dendooven A, Meysman P, et al
    Plasma donor-derived cell-free DNA kinetics after kidney transplantation using a single tube multiplex PCR assay.
    PLoS One. 2018;13:e0208207.
    PubMed     Abstract available


  107. KIM DG, Choi HY, Kim HY, Lee EJ, et al
    Association between post-transplant serum uric acid levels and kidney transplantation outcomes.
    PLoS One. 2018;13:e0209156.
    PubMed     Abstract available


  108. VEROUX M, Gozzo C, Corona D, Murabito P, et al
    Change in kidney volume after kidney transplantation in patients with autosomal polycystic kidney disease.
    PLoS One. 2018;13:e0209332.
    PubMed     Abstract available


  109. CHANCHAROENTHANA W, Leelahavanichkul A, Wattanatorn S, Avihingsanon Y, et al
    Alteration of urinary neutrophil gelatinase-associated lipocalin as a predictor of tacrolimus-induced chronic renal allograft fibrosis in tacrolimus dose adjustments following kidney transplantation.
    PLoS One. 2018;13:e0209708.
    PubMed     Abstract available


  110. KOSOKU A, Uchida J, Nishide S, Kabei K, et al
    ABO-incompatible kidney transplantation as a renal replacement therapy-A single low-volume center experience in Japan.
    PLoS One. 2018;13:e0208638.
    PubMed     Abstract available


  111. DANGARDT F, Charakida M, Chiesa S, Bhowruth D, et al
    Intimal and medial arterial changes defined by ultra-high-frequency ultrasound: Response to changing risk factors in children with chronic kidney disease.
    PLoS One. 2018;13:e0198547.
    PubMed     Abstract available


  112. FERDOSI S, Ho TH, Castle EP, Stanton ML, et al
    Behavior of blood plasma glycan features in bladder cancer.
    PLoS One. 2018;13:e0201208.
    PubMed     Abstract available


  113. BARBAS AS, Lin L, McRae M, MacDonald AL, et al
    Heparan sulfate is a plasma biomarker of acute cellular allograft rejection.
    PLoS One. 2018;13:e0200877.
    PubMed     Abstract available


  114. LEE JH, Park WY, Kim YS, Choi BS, et al
    Clinical significance of the Kidney Donor Profile Index in deceased donors for prediction of post-transplant clinical outcomes: A multicenter cohort study.
    PLoS One. 2018;13:e0205011.
    PubMed     Abstract available


  115. HELD PJ, McCormick F, Chertow GM, Peters TG, et al
    Would government compensation of living kidney donors exploit the poor? An empirical analysis.
    PLoS One. 2018;13:e0205655.
    PubMed     Abstract available


    January 2017
  116. YU JH, Chung BH, Yang CW
    Impact of ABO incompatible kidney transplantation on living donor transplantation.
    PLoS One. 2017;12:e0173878.
    PubMed     Abstract available


  117. MAJAK GB, Reisaeter AV, Zucknick M, Lorentzen B, et al
    Preeclampsia in kidney transplanted women; Outcomes and a simple prognostic risk score system.
    PLoS One. 2017;12:e0173420.
    PubMed     Abstract available


  118. STRIBOS EGD, Nielsen SH, Brix S, Karsdal MA, et al
    Non-invasive quantification of collagen turnover in renal transplant recipients.
    PLoS One. 2017;12:e0175898.
    PubMed     Abstract available


  119. YAMAKAWA RH, Saito PK, Gelmini GF, da Silva JS, et al
    MICA diversity and linkage disequilibrium with HLA-B alleles in renal-transplant candidates in southern Brazil.
    PLoS One. 2017;12:e0176072.
    PubMed     Abstract available


  120. DANUSER B, Simcox A, Studer R, Koller M, et al
    Employment 12 months after kidney transplantation: An in-depth bio-psycho-social analysis of the Swiss Transplant Cohort.
    PLoS One. 2017;12:e0175161.
    PubMed     Abstract available


  121. LASSALLE M, Fezeu LK, Couchoud C, Hannedouche T, et al
    Obesity and access to kidney transplantation in patients starting dialysis: A prospective cohort study.
    PLoS One. 2017;12:e0176616.
    PubMed     Abstract available


  122. ZAZA G, Dalla Gassa A, Felis G, Granata S, et al
    Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen.
    PLoS One. 2017;12:e0178228.
    PubMed     Abstract available


  123. AMDISEN C, Jespersen B, Moldrup U, Keller AK, et al
    The unsuitability of implantable Doppler probes for the early detection of renal vascular complications - a porcine model for prevention of renal transplant loss.
    PLoS One. 2017;12:e0178301.
    PubMed     Abstract available


  124. TROJAN K, Unterrainer C, Weimer R, Bulut N, et al
    Correction: Helios expression and Foxp3 TSDR methylation of IFNy+ and IFNy- Treg from kidney transplant recipients with good long-term graft function.
    PLoS One. 2017;12:e0179069.
    PubMed     Abstract available


  125. DEWOLFE D, Gandhi J, Mackenzie MR, Broge TA Jr, et al
    Pre-transplant immune factors may be associated with BK polyomavirus reactivation in kidney transplant recipients.
    PLoS One. 2017;12:e0177339.
    PubMed     Abstract available


  126. TARTAGLIONE L, Pasquali M, Rotondi S, Muci ML, et al
    Interactions of sclerostin with FGF23, soluble klotho and vitamin D in renal transplantation.
    PLoS One. 2017;12:e0178637.
    PubMed     Abstract available


  127. ALLAREDDY V, Rampa S, Rotta AT, Allareddy V, et al
    The impact of septicemia occurring during hospitalization for renal transplantation procedures on outcomes in adults in United States.
    PLoS One. 2017;12:e0179466.
    PubMed     Abstract available


  128. GARD L, van Doesum W, Niesters HGM, van Son WJ, et al
    A delicate balance between rejection and BK polyomavirus associated nephropathy; A retrospective cohort study in renal transplant recipients.
    PLoS One. 2017;12:e0178801.
    PubMed     Abstract available


  129. KORMANN R, Francois H, Moles T, Dantal J, et al
    Plasma cell neoplasia after kidney transplantation: French cohort series and review of the literature.
    PLoS One. 2017;12:e0179406.
    PubMed     Abstract available


  130. MATIGNON M, Pilon C, Commereuc M, Grondin C, et al
    Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study.
    PLoS One. 2017;12:e0178572.
    PubMed     Abstract available


  131. LI M, Dai Y, Lei J, Tang J, et al
    Acute rejection after kidney transplantation promotes graft fibrosis with elevated adenosine level in rat.
    PLoS One. 2017;12:e0180211.
    PubMed     Abstract available


  132. LITTERA R, Piredda G, Argiolas D, Lai S, et al
    KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation.
    PLoS One. 2017;12:e0180831.
    PubMed     Abstract available


  133. PREMAUD A, Filloux M, Gatault P, Thierry A, et al
    An adjustable predictive score of graft survival in kidney transplant patients and the levels of risk linked to de novo donor-specific anti-HLA antibodies.
    PLoS One. 2017;12:e0180236.
    PubMed     Abstract available


  134. KEDDIS MT, El-Zoghby Z, Kaplan B, Meeusen JW, et al
    Soluble ST2 does not change cardiovascular risk prediction compared to cardiac troponin T in kidney transplant candidates.
    PLoS One. 2017;12:e0181123.
    PubMed     Abstract available


  135. CHANG JY, Yu J, Chung BH, Yang J, et al
    Immunosuppressant prescription pattern and trend in kidney transplantation: A multicenter study in Korea.
    PLoS One. 2017;12:e0183826.
    PubMed     Abstract available


  136. HVIID CJ, Lund M, Sorensen A, Ellermann-Eriksen S, et al
    Detection of Pneumocystis jirovecii in oral wash from immunosuppressed patients as a diagnostic tool.
    PLoS One. 2017;12:e0174012.
    PubMed     Abstract available


  137. BASSI R, Niewczas MA, Biancone L, Bussolino S, et al
    Metabolomic Profiling in Individuals with a Failing Kidney Allograft.
    PLoS One. 2017;12:e0169077.
    PubMed     Abstract available


  138. HAN M, Lee JP, Park S, Kim Y, et al
    Early onset hyperuricemia is a prognostic marker for kidney graft failure: Propensity score matching analysis in a Korean multicenter cohort.
    PLoS One. 2017;12:e0176786.
    PubMed     Abstract available


  139. SEO JW, Moon H, Kim SY, Moon JY, et al
    Both absolute and relative quantification of urinary mRNA are useful for non-invasive diagnosis of acute kidney allograft rejection.
    PLoS One. 2017;12:e0180045.
    PubMed     Abstract available


  140. LAFRANCA JA, Spoon EQW, van de Wetering J, IJzermans JNM, et al
    Attitudes among transplant professionals regarding shifting paradigms in eligibility criteria for live kidney donation.
    PLoS One. 2017;12:e0181846.
    PubMed     Abstract available


  141. MAIGA S, Allain G, Hauet T, Roumy J, et al
    Renal auto-transplantation promotes cortical microvascular network remodeling in a preclinical porcine model.
    PLoS One. 2017;12:e0181067.
    PubMed     Abstract available


  142. TSAI DF, Huang SW, Holm S, Lin YP, et al
    The outcomes and controversies of transplant tourism-Lessons of an 11-year retrospective cohort study from Taiwan.
    PLoS One. 2017;12:e0178569.
    PubMed     Abstract available


  143. ZHU L, Aly M, Wang H, Karakizlis H, et al
    Decreased NK cell immunity in kidney transplant recipients late post-transplant and increased NK-cell immunity in patients with recurrent miscarriage.
    PLoS One. 2017;12:e0186349.
    PubMed     Abstract available


  144. TALSMA DT, Katta K, Boersema M, Adepu S, et al
    Increased migration of antigen presenting cells to newly-formed lymphatic vessels in transplanted kidneys by glycol-split heparin.
    PLoS One. 2017;12:e0180206.
    PubMed     Abstract available


  145. PARAJULI N, Shrum S, Tobacyk J, Harb A, et al
    Renal cold storage followed by transplantation impairs expression of key mitochondrial fission and fusion proteins.
    PLoS One. 2017;12:e0185542.
    PubMed     Abstract available


  146. DE ANDRADE LGM, Contti MM, Nga HS, Bravin AM, et al
    Long-term outcomes of the Atypical Hemolytic Uremic Syndrome after kidney transplantation treated with eculizumab as first choice.
    PLoS One. 2017;12:e0188155.
    PubMed     Abstract available


  147. LEE H, Park KH, Ryu JH, Choi AR, et al
    Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients.
    PLoS One. 2017;12:e0189488.
    PubMed     Abstract available


  148. KULKARNI S, Hall I, Formica R, Thiessen C, et al
    Transition probabilities between changing sensitization levels, waitlist activity status and competing-risk kidney transplant outcomes using multi-state modeling.
    PLoS One. 2017;12:e0190277.
    PubMed     Abstract available


  149. SCHUTTE-NUTGEN K, Tholking G, Dahmen M, Becker F, et al
    Is there a "weekend effect" in kidney transplantation?
    PLoS One. 2017;12:e0190227.
    PubMed     Abstract available


  150. KIM MH, Lee YH, Seo JW, Moon H, et al
    Urinary exosomal viral microRNA as a marker of BK virus nephropathy in kidney transplant recipients.
    PLoS One. 2017;12:e0190068.
    PubMed     Abstract available


  151. DOUBLIER S, Zennaro C, Musante L, Spatola T, et al
    Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS.
    PLoS One. 2017;12:e0188045.
    PubMed     Abstract available


  152. THOLKING G, Schuette-Nuetgen K, Vogl T, Dobrindt U, et al
    Male kidney allograft recipients at risk for urinary tract infection?
    PLoS One. 2017;12:e0188262.
    PubMed     Abstract available


    January 2016
  153. LEE KF, Tsai YT, Lin CY, Hsieh CB, et al
    Cancer Incidence among Heart, Kidney, and Liver Transplant Recipients in Taiwan.
    PLoS One. 2016;11:e0155602.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Kidney Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: